Insights

Innovative Drug Platform Cingulate Inc. leverages its proprietary Precision Timed Release technology to develop next-generation pharmaceuticals, specifically targeting conditions like ADHD and anxiety. This innovative approach presents opportunities for strategic partnerships and licensing deals with pharmaceutical firms seeking advanced drug delivery solutions.

Strong Pipeline Progress The successful Phase 3 trial results for CTx-1301 in pediatric ADHD demonstrate the company's clinical and regulatory maturity, making it an attractive partner for stakeholders interested in cutting-edge ADHD therapies or broader neuropsychiatric indications.

Growing Industry Recognition Active participation in industry events such as the AACAP Annual Meeting and positive trial presentations position Cingulate as a credible innovator, which could attract additional collaborations, investment, or licensing opportunities for pharmaceutical partners and research organizations.

Market Expansion Potential While currently focused on ADHD, Cingulate's PTR platform has the potential to be adapted for multiple therapeutic areas, creating opportunities to expand into new markets and diversify its revenue streams by addressing other chronic or complex conditions.

Size and Revenue Opportunities With an estimated revenue range of $10 million to $25 million and a relatively small team, Cingulate presents an accessible target for smaller biotech partnerships or contract research organizations aiming to enhance their portfolio with innovative drug delivery technologies.

Similar companies to Cingulate Inc.

Cingulate Inc. Tech Stack

Cingulate Inc. uses 8 technology products and services including Module Federation, Apple iCloud Mail, core-js, and more. Explore Cingulate Inc.'s tech stack below.

Module Federation
Development
Apple iCloud Mail
Email
core-js
Javascript Libraries
Acquia Cloud Platform
Platform As A Service
HSTS
Security
Adobe Tag Manager
Tag Management
YouTube
Video Players
GoDaddy
Web Hosting

Media & News

Cingulate Inc.'s Email Address Formats

Cingulate Inc. uses at least 2 format(s):

Cingulate Inc. Email Formats	Example	Percentage
FLast@cingulatetherapeutics.com	JDoe@cingulatetherapeutics.com	80%
First.Last@cingulatetherapeutics.com	John.Doe@cingulatetherapeutics.com	12%
FirstLast@cingulatetherapeutics.com	JohnDoe@cingulatetherapeutics.com	4%
FMiddleLast@cingulatetherapeutics.com	JMichaelDoe@cingulatetherapeutics.com	4%
FLast@cingulate.com	JDoe@cingulate.com	91%
FMiddleLast@cingulate.com	JMichaelDoe@cingulate.com	9%

Frequently Asked Questions

Where is Cingulate Inc.'s headquarters located?

Cingulate Inc.'s main headquarters is located at 1901 West 47th Place, Suite 310. The company has employees across 1 continents, including North America.

What is Cingulate Inc.'s phone number?

You can contact Cingulate Inc.'s main corporate office by phone at

+1-862-260-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cingulate Inc.'s stock symbol?

Cingulate Inc. is a publicly traded company; the company's stock symbol is CING.

What is Cingulate Inc.'s official website and social media links?

Cingulate Inc.'s official website is cingulate.com and has social profiles on LinkedIn.

What is Cingulate Inc.'s NAICS code?

Cingulate Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cingulate Inc. have currently?

As of December 2025, Cingulate Inc. has approximately 20 employees across 1 continents, including North America. Key team members include Chief Legal Officer: N. P.Chief Medical Officer: M. B.Chief Science Officer: R. S.. Explore Cingulate Inc.'s employee directory with LeadIQ.

What industry does Cingulate Inc. belong to?

Cingulate Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Cingulate Inc. use?

Cingulate Inc.'s tech stack includes Module FederationApple iCloud Mailcore-jsAcquia Cloud PlatformHSTSAdobe Tag ManagerYouTubeGoDaddy.

What is Cingulate Inc.'s email format?

Cingulate Inc.'s email format typically follows the pattern of FLast@cingulatetherapeutics.com. Find more Cingulate Inc. email formats with LeadIQ.

When was Cingulate Inc. founded?

Cingulate Inc. was founded in 2012.

Cingulate Inc.

Q: What is Cingulate Inc.'s official website and social media links?

Cingulate Inc.'s official website is cingulate.com. Cingulate Inc. has social profiles on LinkedIn.

Q: How many employees does Cingulate Inc. have currently?

Cingulate Inc. has approximately 20 employees.

Q: What technology does Cingulate Inc. use?

Cingulate Inc.'s tech stack includes Modernizr, jQuery, MySQL, Web Vitals, Google Fonts API.

Pharmaceutical ManufacturingKansas, United States11-50 Employees

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.  
 
We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.  
 
With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.